6915 search
Vertex Pharmaceuticals Incorporated
NASDAQ VRTX 408,18 US$ 0,32%
Logo

Why Citigroup Removed Gilead Sciences From Its 'Most Preferred' List

Publié le 30 mars 2015

Pour voir l'article original, cliquez ici .

Les autres articles de la compagnie
RBC Has 4 Biotech Stocks to Buy After Massive Pullback
Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks
Why you shouldn’t read too much into the latest Vertex trial
Biotech stocks on pace to snap 8-day win streak as warnings
Vertex Pharmaceuticals (VRTX) Stock Falls Today on Cystic Fi
Dans la même rubrique
Mozambique Leader Consolidates His Power With Ruling Party P
30/03/15 12:20
Ralph Lauren, SanDisk, Chesapeake Lead the 2015 Worst S&P 50
28/03/15 13:45
Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks
25/03/15 12:45
BUZZ-Centamin: Up on "class leading" dividend
23/03/15 09:11
China Thin-Film Solar Leader Hanergy Opens 60 Stores, Center
22/03/15 23:53
London midday: StanChart, energy stocks lead gains ahead of
18/03/15 00:12
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles 		Actions
Minières 		Or et
Argent 		Marchés La Cote
search 6915
search